Tag: empagliflozin
-
Pharmac Proposes Wider Access to Type 2 Diabetes Medicines in New Zealand
Pharmac's proposal aims to expand access to three key type 2 diabetes medicines by removing ethnicity criteria and lowering risk thresholds. This change, welcomed by ministers, could benefit thousands of New Zealanders, improving health outcomes and reducing hospital admissions.
HealthPolitics and GovernmentMedical ScienceGeneral PoliticsSocial IssuesEconomy PharmacType 2 DiabetesMedicinesHealthcareEmpagliflozinLiraglutideNew Zealand Government